OverviewChartNewsTraderScreen

Morgan Stanley Call 16 DVAX 20.09.../  DE000ME9SKA1  /

Stuttgart
19/08/2024  20:51:23 Chg.- Bid22:00:34 Ask22:00:34 Underlying Strike price Expiration date Option type
0.230EUR - -
Bid Size: -		 -
Ask Size: -		 Dynavax Technologies... 16.00 - 20/09/2024 Call
GlobeNewswire 31/08/2020 Dynavax to Present at the H.C. Wainwright Virtual 22nd Annual Global Investment Conference
GlobeNewswire 13/08/2020 Dynavax Announces Grant to Scale up CpG 1018 Adjuvant Capacity to Support the Global COVID-19 Respon...
GlobeNewswire 06/08/2020 Dynavax Announces Second Quarter 2020 Financial Results
GlobeNewswire 03/08/2020 TriSalus Life Sciences Acquires Dynavax’s SD-101 Oncology Program in Purchase Agreement for up to $2...
GlobeNewswire 30/07/2020 Dynavax to Report Second Quarter 2020 Financial Results and Host Conference Call on August 6, 2020
TeleTrader 23/07/2020 Dynavax, Medigen to collaborate on vaccine
GlobeNewswire 23/07/2020 Dynavax and Medigen Announce Collaboration to Develop a Novel Adjuvanted COVID-19 Vaccine Candidate
GlobeNewswire 21/07/2020 Dynavax Announces the Appointment of Two New Board Members
GlobeNewswire 16/07/2020 Dynavax and Mount Sinai Announce Collaboration to Develop a Universal Influenza Vaccine Candidate wi...
GlobeNewswire 14/07/2020 Dynavax Announces First Participants Dosed in Phase 1 Clinical Trial Evaluating Medicago’s COVID-19 ...
GlobeNewswire 10/07/2020 Dynavax and Times Pharmacy Announce Partnership to Offer HEPLISAV-B® Hepatitis B Vaccine to Customer...
GlobeNewswire 22/06/2020 Dynavax to Present at the H.C. Wainwright Virtual Fireside Chat Series
GlobeNewswire 19/06/2020 Dynavax Announces First Participants Dosed in Phase 1 Clinical Trial Evaluating Clover Biopharmaceut...
GlobeNewswire 09/06/2020 Dynavax Completes Enrollment of Clinical Trial Evaluating HEPLISAV-B in Patients Undergoing Hemodial...
GlobeNewswire 28/05/2020 Dynavax to Present at the William Blair 40th Annual Growth Stock Conference
GlobeNewswire 27/05/2020 Dynavax Technologies Announces Closing of $80.5 Million Public Offering of Common Stock and Full Exe...
GlobeNewswire 22/05/2020 Dynavax Technologies Announces Pricing of $70.0 Million Public Offering of Common Stock
GlobeNewswire 21/05/2020 Dynavax Technologies Announces Proposed Public Offering of Common Stock
GlobeNewswire 07/05/2020 Dynavax Announces First Quarter 2020 Financial Results
GlobeNewswire 28/04/2020 Dynavax Reports Interim Analysis of Ongoing Clinical Trial Evaluating HEPLISAV-B in Patients Undergo...
GlobeNewswire 23/04/2020 Dynavax to Report First Quarter 2020 Financial Results and Host Conference Call on May 7, 2020
TeleTrader 22/04/2020 Valneva, Dynavax join efforts to create COVID-19 vaccine
GlobeNewswire 16/04/2020 Dynavax and Sinovac Announce Collaboration to Develop a Coronavirus (COVID-19) Vaccine
GlobeNewswire 08/04/2020 Dynavax Donates 10,000 Doses of HEPLISAV-B® [Hepatitis B Vaccine (Recombinant), Adjuvanted] Vaccine ...
GlobeNewswire 02/04/2020 Dynavax Provides Business Update on COVID-19 Pandemic Impact